Diabetes type2

24 registered clinical trials studyying Diabetes type2 — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Withdrawn	Benefits of Nutritional Ingredients for Type 2 Diabetes NCT06327711	Abbott Nutrition	N/A
Completed	A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of D745, D759, and D150 NCT05928637	Chong Kun Dang Pharmaceutical	Phase 1
Unknown	Organisational Models Supported by Technology for the Management of Diabetic Disease and Its Complications in NCT05629221	Azienda Sanitaria Universitaria Integrata del Trentino	N/A
Completed	Training on Using ıInsulin in Patients With Type 2 Diabetes NCT05915338	Inonu University	—
Recruiting	Time-Restricted Eating for Type II Diabetes: TRE-T2D NCT05365529	University of California, San Diego	N/A
Completed	Actiste® Diabetes Management as a Service (ADMS) Clinical Investigation NCT05284071	Northern Care Alliance NHS Foundation Trust	N/A
Not Yet Recruiting	Impact of Obesity, Chronic Kidney Disease and Type 2 Diabetes on Human Urinary Stem Cells NCT04998461	Hospices Civils de Lyon	—
Completed	Acceptance and Commitment Therapy Principles for Diabetes Prevention NCT05260983	University of Oregon	N/A
Recruiting	Diabetic Nephropathy in People With Diabetes. Prevalence and Predictive Factors NCT04916132	Herlev Hospital	—
Completed	Dietary Approaches to Stop Hypertension for Diabetes NCT04286555	Johns Hopkins University	N/A
Recruiting	Digital Individualized and Collaborative Treatment of T2D in General Practice Based on Decision Aid NCT04880005	University of Southern Denmark	N/A
Recruiting	Intermittent Fasting to Improve Insulin Secretion NCT04607096	University Hospital Tuebingen	N/A
Terminated	Primary Care Based Integrated Community Care Team Intervention NCT04819256	SingHealth Polyclinics	N/A
Completed	Effect of Totum-63 on Glucose and Lipid Homeostasis in Subjects With Dysglycemia (REVERSE-IT) NCT04423302	Valbiotis	N/A
Unknown	16-week Flexible vs. 8-week Semaglutide Titration NCT04447859	Tel-Aviv Sourasky Medical Center	Phase 3
Unknown	NASH and Type 2 Diabetes: Role of the Receptor Activator of Nuclear Factor-κB (RANK) and Its Ligand (RANKL) NCT03968354	Assistance Publique - Hôpitaux de Paris	—
Unknown	A Real World Research: Comparison of Precision and Experience Therapy for Hypertension, Diabetes or Hyperlipid NCT04660630	Beijing Chao Yang Hospital	N/A
Unknown	The Occurence of Pancreatic Cancer Studied in Association With Newly Diagnosed Diabetes in the Elderly NCT04164602	University of Pecs	—
Recruiting	RESET System Pivotal Trial (Rev F) NCT04101669	Morphic Medical Inc.	N/A
Unknown	The Canadian Diabetes Prevention Program NCT05784220	LMC Diabetes & Endocrinology Ltd.	N/A
Completed	Epigenetic and Microbiota Modifications NCT05076656	Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud	EARLY_Phase 1
Unknown	Effects of Short-term Intensive De-escalation Therapy on Long-term Regimen Simplification NCT03958591	Yanbing Li	Phase 4
Completed	Diabetes Reversal and the Subgingival Microbiota NCT05501093	University of Pennsylvania	—
Unknown	Hyposalivation Response To Transcutaneous Electrical Nerve Stimulation In Diabetic Type 2 Patients NCT03435328	Cairo University	N/A